Lexpos News

/Lexpos News

Reducing teenage pregnancy – How community pharmacy and local government collaboration has driven progress

Teenage pregnancy has long been a marker of health inequality in England. The provision of locally commissioned sexual health services, including those provided by community pharmacies, has been part of local authority efforts to tackle local health inequalities and improve outcomes. A report from the Local Government Association (LGA)  highlights how local government working with [...]

The post Reducing teenage pregnancy – How community pharmacy and local government collaboration has driven progress appeared first on Community Pharmacy England.

By |December 18th, 2025|Lexpos News|Comments Off on Reducing teenage pregnancy – How community pharmacy and local government collaboration has driven progress

MHRA Drug Safety Update: Rybelsus® (semaglutide tablets): transition to new formulation and risk of medication error

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance regarding the transition to the new formulation and risk of medication error with Rybelsus® tablets. There is a risk of patient harm arising through medication error during a transition period where the original and new formulation of Rybelsus® tablets, which have different stated mg [...]

The post MHRA Drug Safety Update: Rybelsus® (semaglutide tablets): transition to new formulation and risk of medication error appeared first on Community Pharmacy England.

By |December 17th, 2025|Lexpos News|Comments Off on MHRA Drug Safety Update: Rybelsus® (semaglutide tablets): transition to new formulation and risk of medication error

MHRA Drug Safety Update: Rybelsus® (semaglutide tablets): transition to new formulation and risk of medication error

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance regarding the transition to the new formulation and risk of medication error with Rybelsus® tablets. There is a risk of patient harm arising through medication error during a transition period where the original and new formulation of Rybelsus® tablets, which have different stated mg [...]

The post MHRA Drug Safety Update: Rybelsus® (semaglutide tablets): transition to new formulation and risk of medication error appeared first on Community Pharmacy England.

By |December 17th, 2025|Lexpos News|Comments Off on MHRA Drug Safety Update: Rybelsus® (semaglutide tablets): transition to new formulation and risk of medication error

Pharmacy supervision legislation to come into force in 2026

The Department of Health and Social Care has announced that The Human Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025 has been approved by Parliament and the Privy Council, and will come into force in two stages. The order makes changes to The Medicines Act 1968 and The Human Medicines Regulations 2012 [...]

The post Pharmacy supervision legislation to come into force in 2026 appeared first on Community Pharmacy England.

By |December 17th, 2025|Lexpos News|Comments Off on Pharmacy supervision legislation to come into force in 2026

C-19 & Adult Flu vac: joint 2026/27 service spec published, with fee uplifts from April 2026

Summary: New joint service specification for COVID-19 and adult flu vaccinations published. COVID-19 vaccinations become an Advanced service. Fees for both vaccinations uplifted, but additional fee for housebound patients removed. Pharmacy owners must use the National Booking Service (NBS) for COVID-19 vaccinations, but this is still not a requirement for flu. Registration for spring COVID-19 [...]

The post C-19 & Adult Flu vac: joint 2026/27 service spec published, with fee uplifts from April 2026 appeared first on Community Pharmacy England.

By |December 15th, 2025|Lexpos News|Comments Off on C-19 & Adult Flu vac: joint 2026/27 service spec published, with fee uplifts from April 2026